A handout by DRAP on its official website late Monday read that Sinopharm, one of the two vaccines approved by the authority, has been given emergency use authorization after evaluating its safety and quality.
The authority said the authorization will be reviewed every quarter keeping in view further data regarding safety, efficacy and quality.
A vaccine manufactured by British-Swedish pharmaceutical company AstraZeneca has also been given the authorization earlier, the handout said.
Chaudhry Fawad Hussain, the country’s minister for science and technology, told Xinhua earlier that the Sinopharm vaccine has been approved for procurement by a cabinet committee for its safety and affordability.
Short Link: https://wp.me/pcj2iU-3xG3
- Super league – FIFA chief Infantino: “We need to face the problems in football together”
- Forum tasks FG on MSMEs growth
- Video press release: Rugby Africa Sevens Solidarity Camp: All matches will be broadcast live Saturday and Sunday on Rugby Africa’s Facebook page and Rugby Africa’s YouTube channel
- APC will take over Rivers Govt House in 2023- State Chairman
- Coronavirus – Nigeria: COVID-19 case update (May 7, 2021)
- FRSC enjoins passengers to caution reckless drivers
- Coronavirus – Daily update of the state of COVID-19 statistics in Zambia (May 7, 2021)
- Atiku mourns ex-Minister of Women Affairs, Alhassan
- Bird flu: Bauchi govt. kills about 27,000 birds to curtail spread